Heidi L. Weiss, PhD
Heidi L. Weiss, PhD
- Associate Director, Shared Resource Facilities
- Director, Biostatistics Shared Resource Facility
About
Faculty Rank
- Professor
Research
Research Focus
Design and analysis of early phase clinical trials focusing on Bayesian design and interim monitoring. Statistical analysis of transgenic, xenograft and chemically induced mouse models of cancer.
Programs
Translational OncologyCollege & Department
Contact Information
800 Rose Street
CC448 Roach Building, University of Kentucky
Lexington, KY 40536
United States
Phone
Email
Publications
- A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.Massarweh S, Tham YL, Huang J, Sexton K, Weiss H, Tsimelzon A, Beyer A, Rimawi M, Cai WY, Hilsenbeck S, Fuqua S and Elledge R. Breast Cancer Res Treat 129:819-27, 2011.
- Bayesian Monitoring of a phase II chemoprevention trial in high risk cohorts for prostate cancer.Weiss HL, Urban DA, Grizzle WE, Cronin KA, Freedman LS, Kelloff GJ, Lieberman R. Urology 57(4A):220-223, 2001.